CDD3505

CDD3505 is used for elevating high density lipoprotein cholesterol (HDL) by inducing hepatic cytochrome P450IIIA (CYP3A) activity.

Cytochrome P450

Reference compound

Metabolic Enzyme/Protease

Metabolism-sugar/lipid metabolism

Metabolic Disease

https://www.medchemexpress.com/CDD3505.html

98.0

DMSO : 14.29 mg/mL (ultrasonic)

O=[N+]([O-])C1=CN(C(C2=CC=CC=C2)(C3=CC=CC=C3)C4=CC=CC=C4)C=N1

355.39

[1]Method for increasing HDL cholesterol levels?using?heteroaromatic phenylmethanes. United States Patent 6103733

Room Temperature

-20°C, 3 years; 4°C, 2 years (Powder)

http://file.medchemexpress.com/batch_PDF/HY-100901/CDD3505-DataSheet-MedChemExpress.pdf

http://file.medchemexpress.com/batch_PDF/HY-100901/CDD3505-SDS-MedChemExpress.pdf

No Development Reported

173865-33-3